TP53 and cancer: In a series of 48 thymic carcinomas assessed for mutations in 50 cancer-related genes, the TP53 pathway was the most frequently affected (20.4%), followed by the receptor tyrosine kinase/RAS pathway (18.5%), and the PI3K pathway (5.6%) [28].